XENE
Xenon Pharmaceuticals Inc
stockNASDAQ
At CloseNov 3, 2026 3:59:58 PM EST
38.23USD+1.621%(+0.61)1,246,675
Pre-marketNov 3, 2026 9:28:30 AM EST
37.75USD+0.346%(+0.13)
XENE Financials
In Q2 FY 2026 (ended ), Xenon Pharmaceuticals Inc (XENE) reported revenue of $0, net income of −$110.74M, operating cash flow of −$95.39M, and assets of $1.3B.
Loading financial flows…